1
|
Fotinós J, Barberis L, Condat CA. Effects of a differentiating therapy on cancer-stem-cell-driven tumors. J Theor Biol 2023; 572:111563. [PMID: 37391126 DOI: 10.1016/j.jtbi.2023.111563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2023] [Revised: 05/22/2023] [Accepted: 06/18/2023] [Indexed: 07/02/2023]
Abstract
The growth of many solid tumors has been found to be driven by chemo- and radiotherapy-resistant cancer stem cells (CSCs). A suitable therapeutic avenue in these cases may involve the use of a differentiating agent (DA) to force the differentiation of the CSCs and of conventional therapies to eliminate the remaining differentiated cancer cells (DCCs). To describe the effects of a DA that reprograms CSCs into DCCs, we adapt a differential equation model developed to investigate tumorspheres, which are assumed to consist of jointly evolving CSC and DCC populations. We analyze the mathematical properties of the model, finding the equilibria and their stability. We also present numerical solutions and phase diagrams to describe the system evolution and the therapy effects, denoting the DA strength by a parameter adif. To obtain realistic predictions, we choose the other model parameters to be those determined previously from fits to various experimental datasets. These datasets characterize the progression of the tumor under various culture conditions. Typically, for small values of adif the tumor evolves towards a final state that contains a CSC fraction, but a strong therapy leads to the suppression of this phenotype. Nonetheless, different external conditions lead to very diverse behaviors. For microchamber-grown tumorspheres, there is a threshold in therapy strength below which both subpopulations survive, while high values of adif lead to the complete elimination of the CSC phenotype. For tumorspheres grown on hard and soft agar and in the presence of growth factors, the model predicts a threshold not only in the therapy strength, but also in its starting time, an early beginning being potentially crucial. In summary, our model shows how the effects of a DA depend critically not only on the dosage and timing of the drug application, but also on the tumor nature and its environment.
Collapse
Affiliation(s)
- J Fotinós
- Instituto de Física Enrique Gaviola, CONICET, 5000, Córdoba, Argentina; FaMAF, Universidad Nacional de Córdoba, Bvd. Medina Allende s/n, Ciudad Universitaria, 5000, Córdoba, Argentina.
| | - L Barberis
- Instituto de Física Enrique Gaviola, CONICET, 5000, Córdoba, Argentina; FaMAF, Universidad Nacional de Córdoba, Bvd. Medina Allende s/n, Ciudad Universitaria, 5000, Córdoba, Argentina
| | - C A Condat
- Instituto de Física Enrique Gaviola, CONICET, 5000, Córdoba, Argentina; FaMAF, Universidad Nacional de Córdoba, Bvd. Medina Allende s/n, Ciudad Universitaria, 5000, Córdoba, Argentina
| |
Collapse
|
2
|
Lavalle NG, Chara O, Grigera TS. Fluctuations in tissue growth portray homeostasis as a critical state and long-time non-Markovian cell proliferation as Markovian. ROYAL SOCIETY OPEN SCIENCE 2023; 10:230871. [PMID: 37711142 PMCID: PMC10498046 DOI: 10.1098/rsos.230871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Accepted: 08/24/2023] [Indexed: 09/16/2023]
Abstract
Tissue growth is an emerging phenomenon that results from the cell-level interplay between proliferation and apoptosis, which is crucial during embryonic development, tissue regeneration, as well as in pathological conditions such as cancer. In this theoretical article, we address the problem of stochasticity in tissue growth by first considering a minimal Markovian model of tissue size, quantified as the number of cells in a simulated tissue, subjected to both proliferation and apoptosis. We find two dynamic phases, growth and decay, separated by a critical state representing a homeostatic tissue. Since the main limitation of the Markovian model is its neglect of the cell cycle, we incorporated a refractory period that temporarily prevents proliferation immediately following cell division, as a minimal proxy for the cell cycle, and studied the model in the growth phase. Importantly, we obtained from this last model an effective Markovian rate, which accurately describes general trends of tissue size. This study shows that the dynamics of tissue growth can be theoretically conceptualized as a Markovian process where homeostasis is a critical state flanked by decay and growth phases. Notably, in the growing non-Markovian model, a Markovian-like growth process emerges at large time scales.
Collapse
Affiliation(s)
- Natalia G. Lavalle
- Instituto de Física de Líquidos y Sistemas Biológicos (IFLySiB), Universidad Nacional de La Plata and CONICET, Calle 59 n. 789, La Plata B1900BTE, Argentina
| | - Osvaldo Chara
- School of Biosciences, University of Nottingham, Sutton Bonington Campus, Nottingham LE12 5RD, UK
- Instituto de Tecnología, Universidad Argentina de la Empresa, Buenos Aires C1073AAO, Argentina
| | - Tomás S. Grigera
- Instituto de Física de Líquidos y Sistemas Biológicos (IFLySiB), Universidad Nacional de La Plata and CONICET, Calle 59 n. 789, La Plata B1900BTE, Argentina
- CCT CONICET La Plata, Consejo Nacional de Investigaciones Científicas y Técnicas, La Plata, Argentina
- Departamento de Física, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina
- Istituto dei Sistemi Complessi, Consiglio Nazionale delle Ricerche, via dei Taurini 19, Rome 00185, Italy
| |
Collapse
|
3
|
Lagzian M, Ehsan Razavi S, Goharimanesh M. Investigation on tumor cells growth by Taguchi method. Biomed Signal Process Control 2022. [DOI: 10.1016/j.bspc.2022.103734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
4
|
Shende P, Devlekar NP. A Review on the Role of Artificial Intelligence in Stem Cell Therapy: An Initiative for Modern Medicines. Curr Pharm Biotechnol 2021; 22:1156-1163. [PMID: 33030129 DOI: 10.2174/1389201021666201007122524] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 08/12/2020] [Accepted: 09/01/2020] [Indexed: 11/22/2022]
Abstract
Stem Cells (SCs) show a wide range of applications in the treatment of numerous diseases, including neurodegenerative diseases, diabetes, cardiovascular diseases, cancer, etc. SC related research has gained popularity owing to the unique characteristics of self-renewal and differentiation. Artificial Intelligence (AI), an emerging field of computer science and engineering, has shown potential applications in different fields like robotics, agriculture, home automation, healthcare, banking, and transportation since its invention. This review aims to describe the various applications of AI in SC biology, including understanding the behavior of SCs, recognizing individual cell type before undergoing differentiation, characterization of SCs using mathematical models and prediction of mortality risk associated with SC transplantation. This review emphasizes the role of neural networks in SC biology and further elucidates the concepts of machine learning and deep learning and their applications in SC research.
Collapse
Affiliation(s)
- Pravin Shende
- Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management SVKM's NMIMS, V.L Mehta Road, Vile Parle (W), Mumbai, India
| | - Nikita P Devlekar
- Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management SVKM's NMIMS, V.L Mehta Road, Vile Parle (W), Mumbai, India
| |
Collapse
|
5
|
NAZARI FERESHTEH, PEARSON ALEXANDERT, JACKSON TRACHETTEL. MATHEMATICAL CHARACTERIZATION OF HETEROGENEITY IN A CANCER STEM CELL DRIVEN TUMOR GROWTH MODEL WITH NONLINEAR SELF-RENEWAL. J BIOL SYST 2021. [DOI: 10.1142/s0218339021500029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The detection, in a wide variety of cancer types, of a population of highly tumorigenic cells that exhibit self-renewal and multipotency, which are hallmarks of stem cells, has transformed the current view of tumor initiation, progression, and treatment. Here, we develop and analyze a mathematical model for tumor growth that is based on the current biological understanding of the processes that underlie cellular expansion under the hierarchical guidelines of the cancer stem cell (CSC) hypothesis. Important features of the model include (i) a nonlinear probability of CSC self-renewal that reflects the fact that this key type of stem cell division can be regulated by extrinsic and intrinsic chemical signaling as well as environmental (niche) constraints and (ii) an amplification factor that captures the transient amplifying divisions that are a defining characteristic of progenitor cells. We present a thorough mathematical analysis of the model and highlight the conditions required for tumors to evolve toward either bounded or exponential growth. Numerical simulations further illustrate the impact of the various parameters on the tumor growth rate and on the heterogeneous cellular composition, which varies during progression.
Collapse
Affiliation(s)
- FERESHTEH NAZARI
- Applied BioMath, 210 Broadway, Suite 201, Cambridge, MA 02139, USA
| | - ALEXANDER T PEARSON
- Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL 60637, USA
| | - TRACHETTE L JACKSON
- Department of Mathematics, University of Michigan, 530 Church Street, Ann Arbor, MI 48108-1043, USA
| |
Collapse
|
6
|
Salichos L, Meyerson W, Warrell J, Gerstein M. Estimating growth patterns and driver effects in tumor evolution from individual samples. Nat Commun 2020; 11:732. [PMID: 32024824 PMCID: PMC7002450 DOI: 10.1038/s41467-020-14407-9] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2018] [Accepted: 11/26/2019] [Indexed: 01/01/2023] Open
Abstract
Tumors accumulate thousands of mutations, and sequencing them has given rise to methods for finding cancer drivers via mutational recurrence. However, these methods require large cohorts and underperform for low recurrence. Recently, ultra-deep sequencing has enabled accurate measurement of VAFs (variant-allele frequencies) for mutations, allowing the determination of evolutionary trajectories. Here, based solely on the VAF spectrum for an individual sample, we report on a method that identifies drivers and quantifies tumor growth. Drivers introduce perturbations into the spectrum, and our method uses the frequency of hitchhiking mutations preceding a driver to measure this. As validation, we use simulation models and 993 tumors from the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium with previously identified drivers. Then we apply our method to an ultra-deep sequenced acute myeloid leukemia (AML) tumor and identify known cancer genes and additional driver candidates. In summary, our framework presents opportunities for personalized driver diagnosis using sequencing data from a single individual.
Collapse
Affiliation(s)
- Leonidas Salichos
- Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, 06520, USA
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520, USA
| | - William Meyerson
- Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, 06520, USA
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520, USA
| | - Jonathan Warrell
- Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, 06520, USA
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520, USA
| | - Mark Gerstein
- Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, 06520, USA.
- Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520, USA.
- Department of Computer Science, Yale University, New Haven, CT, 06520, USA.
- Center for Biomedical Data Science, Yale University, New Haven, CT, 06520, USA.
| |
Collapse
|
7
|
Afenya EK, Ouifki R, Mundle SD. Mathematical modeling of bone marrow - peripheral blood dynamics in the disease state based on current emerging paradigms, part II. J Theor Biol 2019; 460:37-55. [PMID: 30296448 DOI: 10.1016/j.jtbi.2018.10.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2017] [Revised: 09/28/2018] [Accepted: 10/01/2018] [Indexed: 12/31/2022]
Abstract
The cancer stem cell hypothesis has gained currency in recent times but concerns remain about its scientific foundations because of significant gaps that exist between research findings and comprehensive knowledge about cancer stem cells (CSCs). In this light, a mathematical model that considers hematopoietic dynamics in the diseased state of the bone marrow and peripheral blood is proposed and used to address findings about CSCs. The ensuing model, resulting from a modification and refinement of a recent model, develops out of the position that mathematical models of CSC development, that are few at this time, are needed to provide insightful underpinnings for biomedical findings about CSCs as the CSC idea gains traction. Accordingly, the mathematical challenges brought on by the model that mirror general challenges in dealing with nonlinear phenomena are discussed and placed in context. The proposed model describes the logical occurrence of discrete time delays, that by themselves present mathematical challenges, in the evolving cell populations under consideration. Under the challenging circumstances, the steady state properties of the model system of delay differential equations are obtained, analyzed, and the resulting mathematical predictions arising therefrom are interpreted and placed within the framework of findings regarding CSCs. Simulations of the model are carried out by considering various parameter scenarios that reflect different experimental situations involving disease evolution in human hosts. Model analyses and simulations suggest that the emergence of the cancer stem cell population alongside other malignant cells engenders higher dimensions of complexity in the evolution of malignancy in the bone marrow and peripheral blood at the expense of healthy hematopoietic development. The model predicts the evolution of an aberrant environment in which the malignant population particularly in the bone marrow shows tendencies of reaching an uncontrollable equilibrium state. Essentially, the model shows that a structural relationship exists between CSCs and non-stem malignant cells that confers on CSCs the role of temporally enhancing and stimulating the expansion of non-stem malignant cells while also benefitting from increases in their own population and these CSCs may be the main protagonists that drive the ultimate evolution of the uncontrollable equilibrium state of such malignant cells and these may have implications for treatment.
Collapse
Affiliation(s)
- Evans K Afenya
- Department of Mathematics, Elmhurst College, 190 Prospect Avenue, Elmhurst, IL 60126, USA.
| | - Rachid Ouifki
- Department of Mathematics and Applied Mathematics, University of Pretoria, South Africa.
| | - Suneel D Mundle
- Department of Biochemistry, Rush University Medical Center, 1735 W. Harrison St, Chicago, IL 60612, USA.
| |
Collapse
|
8
|
Gavagnin E, Yates CA. Stochastic and Deterministic Modeling of Cell Migration. HANDBOOK OF STATISTICS 2018. [DOI: 10.1016/bs.host.2018.06.002] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
9
|
Mahdipour-Shirayeh A, Kaveh K, Kohandel M, Sivaloganathan S. Phenotypic heterogeneity in modeling cancer evolution. PLoS One 2017; 12:e0187000. [PMID: 29084232 PMCID: PMC5662227 DOI: 10.1371/journal.pone.0187000] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2017] [Accepted: 10/11/2017] [Indexed: 12/14/2022] Open
Abstract
The unwelcome evolution of malignancy during cancer progression emerges through a selection process in a complex heterogeneous population structure. In the present work, we investigate evolutionary dynamics in a phenotypically heterogeneous population of stem cells (SCs) and their associated progenitors. The fate of a malignant mutation is determined not only by overall stem cell and non-stem cell growth rates but also differentiation and dedifferentiation rates. We investigate the effect of such a complex population structure on the evolution of malignant mutations. We derive exactly calculated results for the fixation probability of a mutant arising in each of the subpopulations. The exactly calculated results are in almost perfect agreement with the numerical simulations. Moreover, a condition for evolutionary advantage of a mutant cell versus the wild type population is given in the present study. We also show that microenvironment-induced plasticity in invading mutants leads to more aggressive mutants with higher fixation probability. Our model predicts that decreasing polarity between stem and non-stem cells’ turnover would raise the survivability of non-plastic mutants; while it would suppress the development of malignancy for plastic mutants. The derived results are novel and general with potential applications in nature; we discuss our model in the context of colorectal/intestinal cancer (at the epithelium). However, the model clearly needs to be validated through appropriate experimental data. This novel mathematical framework can be applied more generally to a variety of problems concerning selection in heterogeneous populations, in other contexts such as population genetics, and ecology.
Collapse
Affiliation(s)
| | - Kamran Kaveh
- Program for Evolutionary Dynamics, Harvard University, Cambridge, United States of America
| | - Mohammad Kohandel
- Department of Applied Mathematics, University of Waterloo, Waterloo, Canada
- Center for Mathematical Medicine, Fields Institute, Toronto, Canada
| | - Sivabal Sivaloganathan
- Department of Applied Mathematics, University of Waterloo, Waterloo, Canada
- Center for Mathematical Medicine, Fields Institute, Toronto, Canada
| |
Collapse
|
10
|
Kaveh K. Stem Cell Evolutionary Dynamics of Differentiation and Plasticity. CURRENT STEM CELL REPORTS 2017. [DOI: 10.1007/s40778-017-0109-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Yates CA, Ford MJ, Mort RL. A Multi-stage Representation of Cell Proliferation as a Markov Process. Bull Math Biol 2017; 79:2905-2928. [PMID: 29030804 PMCID: PMC5709504 DOI: 10.1007/s11538-017-0356-4] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2017] [Accepted: 09/28/2017] [Indexed: 01/08/2023]
Abstract
The stochastic simulation algorithm commonly known as Gillespie’s algorithm (originally derived for modelling well-mixed systems of chemical reactions) is now used ubiquitously in the modelling of biological processes in which stochastic effects play an important role. In well-mixed scenarios at the sub-cellular level it is often reasonable to assume that times between successive reaction/interaction events are exponentially distributed and can be appropriately modelled as a Markov process and hence simulated by the Gillespie algorithm. However, Gillespie’s algorithm is routinely applied to model biological systems for which it was never intended. In particular, processes in which cell proliferation is important (e.g. embryonic development, cancer formation) should not be simulated naively using the Gillespie algorithm since the history-dependent nature of the cell cycle breaks the Markov process. The variance in experimentally measured cell cycle times is far less than in an exponential cell cycle time distribution with the same mean. Here we suggest a method of modelling the cell cycle that restores the memoryless property to the system and is therefore consistent with simulation via the Gillespie algorithm. By breaking the cell cycle into a number of independent exponentially distributed stages, we can restore the Markov property at the same time as more accurately approximating the appropriate cell cycle time distributions. The consequences of our revised mathematical model are explored analytically as far as possible. We demonstrate the importance of employing the correct cell cycle time distribution by recapitulating the results from two models incorporating cellular proliferation (one spatial and one non-spatial) and demonstrating that changing the cell cycle time distribution makes quantitative and qualitative differences to the outcome of the models. Our adaptation will allow modellers and experimentalists alike to appropriately represent cellular proliferation—vital to the accurate modelling of many biological processes—whilst still being able to take advantage of the power and efficiency of the popular Gillespie algorithm.
Collapse
Affiliation(s)
- Christian A Yates
- Department of Mathematical Sciences, Centre for Mathematical Biology, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
| | - Matthew J Ford
- MRC Human Genetics Unit, MRC IGMM, Western General Hospital, University of Edinburgh, Edinburgh, EH4 2XU, UK
- Department of Human Genetics, Rosalind and Morris Goodman Cancer Research Centre, McGill University, 1160 Pine Avenue West, Montreal, QC, H3A 1A3, Canada
| | - Richard L Mort
- Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Furness Building, Lancaster University, Bailrigg, Lancaster, LA1 4YG, UK
| |
Collapse
|
12
|
Stem cell self-renewal in regeneration and cancer: Insights from mathematical modeling. ACTA ACUST UNITED AC 2017. [DOI: 10.1016/j.coisb.2017.09.006] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
|
13
|
Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer. Part 1: Biological Facts and Studies in Drug Resistance. CURRENT STEM CELL REPORTS 2017. [DOI: 10.1007/s40778-017-0097-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
14
|
Forouzannia F, Sivaloganathan S. Cancer Stem Cells, the Tipping Point: Minority Rules? CURRENT STEM CELL REPORTS 2017. [DOI: 10.1007/s40778-017-0095-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
15
|
Modeling the Treatment of Glioblastoma Multiforme and Cancer Stem Cells with Ordinary Differential Equations. COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE 2016; 2016:1239861. [PMID: 27022405 PMCID: PMC4745194 DOI: 10.1155/2016/1239861] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/03/2015] [Revised: 11/12/2015] [Accepted: 12/22/2015] [Indexed: 11/24/2022]
Abstract
Despite improvements in cancer therapy and treatments, tumor recurrence is a common event in cancer patients. One explanation of recurrence is that cancer therapy focuses on treatment of tumor cells and does not eradicate cancer stem cells (CSCs). CSCs are postulated to behave similar to normal stem cells in that their role is to maintain homeostasis. That is, when the population of tumor cells is reduced or depleted by treatment, CSCs will repopulate the tumor, causing recurrence. In this paper, we study the application of the CSC Hypothesis to the treatment of glioblastoma multiforme by immunotherapy. We extend the work of Kogan et al. (2008) to incorporate the dynamics of CSCs, prove the existence of a recurrence state, and provide an analysis of possible cancerous states and their dependence on treatment levels.
Collapse
|
16
|
Kumar S, Raina K, Agarwal C, Agarwal R. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals. Oncotarget 2015; 5:4972-89. [PMID: 24970802 PMCID: PMC4148115 DOI: 10.18632/oncotarget.2068] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Involvement of cancer stem cells (CSC) in initiation, progression, relapse, and therapy-resistance of colorectal cancer (CRC) warrants search for small molecules as ‘adjunct-therapy’ to target both colon CSC and bulk tumor population. Herein, we assessed the potential of silibinin to eradicate colon CSC together with associated molecular mechanisms. In studies examining how silibinin modulates dynamics of CSC spheroids in terms of its effect on kinetics of CSC spheroids generated in presence of mitogenic and interleukin (IL)-mediated signaling which provides an autocrine/paracrine amplification loop in CRC, silibinin strongly decreased colon CSC pool together with cell survival of bulk tumor cells. Silibinin effect on colon CSC was mediated via blocking of pro-tumorigenic signaling, notably IL-4/-6 signaling that affects CSC population. These silibinin effects were associated with decreased mRNA and protein levels of various CSC-associated transcription factors, signaling molecules and markers. Furthermore, 2D and 3D differentiation assays indicated formation of more differentiated clones by silibinin. These results highlight silibinin potential to interfere with kinetics of CSC pool by shifting CSC cell division to asymmetric type via targeting various signals associated with the survival and multiplication of colon CSC pool. Together, our findings further support clinical usefulness of silibinin in CRC intervention and therapy.
Collapse
Affiliation(s)
- Sushil Kumar
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado. These Authors Contributed equally and share first authorship
| | - Komal Raina
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado. These Authors Contributed equally and share first authorship
| | - Chapla Agarwal
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado. University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| | - Rajesh Agarwal
- Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado. University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado
| |
Collapse
|
17
|
Muñoz AI. Numerical resolution of a model of tumour growth. MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA 2015; 33:57-85. [PMID: 25678684 DOI: 10.1093/imammb/dqv004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/03/2013] [Accepted: 01/21/2015] [Indexed: 11/13/2022]
Abstract
We consider and solve numerically a mathematical model of tumour growth based on cancer stem cells (CSC) hypothesis with the aim of gaining some insight into the relation of different processes leading to exponential growth in solid tumours and into the evolution of different subpopulations of cells. The model consists of four hyperbolic equations of first order to describe the evolution of four subpopulations of cells. A fifth equation is introduced to model the evolution of the moving boundary. The coefficients of the model represent the rates at which reactions occur. In order to integrate numerically the four hyperbolic equations, a formulation in terms of the total derivatives is posed. A finite element discretization is applied to integrate the model equations in space. Our numerical results suggest the existence of a pseudo-equilibrium state reached at the early stage of the tumour, for which the fraction of CSC remains small. We include the study of the behaviour of the solutions for longer times and we obtain that the solutions to the system of partial differential equations stabilize to homogeneous steady states whose values depend only on the values of the parameters. We show that CSC may comprise different proportions of the tumour, becoming, in some cases, the predominant type of cells within the tumour. We also obtain that possible effective measure to detain tumour progression should combine the targeting of CSC with the targeting of progenitor cells.
Collapse
Affiliation(s)
- Ana I Muñoz
- Department of Applied Mathematics, Rey Juan Carlos University, Tulipán Street, Móstoles, Madrid, E 28933, Spain
| |
Collapse
|
18
|
Weekes SL, Barker B, Bober S, Cisneros K, Cline J, Thompson A, Hlatky L, Hahnfeldt P, Enderling H. A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics. Bull Math Biol 2014; 76:1762-82. [PMID: 24840956 DOI: 10.1007/s11538-014-9976-0] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2013] [Accepted: 04/30/2014] [Indexed: 08/30/2023]
Abstract
Tumors are appreciated to be an intrinsically heterogeneous population of cells with varying proliferation capacities and tumorigenic potentials. As a central tenet of the so-called cancer stem cell hypothesis, most cancer cells have only a limited lifespan, and thus cannot initiate or reinitiate tumors. Longevity and clonogenicity are properties unique to the subpopulation of cancer stem cells. To understand the implications of the population structure suggested by this hypothesis--a hierarchy consisting of cancer stem cells and progeny non-stem cancer cells which experience a reduction in their remaining proliferation capacity per division--we set out to develop a mathematical model for the development of the aggregate population. We show that overall tumor progression rate during the exponential growth phase is identical to the growth rate of the cancer stem cell compartment. Tumors with identical stem cell proportions, however, can have different growth rates, dependent on the proliferation kinetics of all participating cell populations. Analysis of the model revealed that the proliferation potential of non-stem cancer cells is likely to be small to reproduce biologic observations. Furthermore, a single compartment of non-stem cancer cell population may adequately represent population growth dynamics only when the compartment proliferation rate is scaled with the generational hierarchy depth.
Collapse
Affiliation(s)
- Suzanne L Weekes
- Department of Mathematical Sciences, Worcester Polytechnic Institute, Worcester, MA , 01609, USA,
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Dhawan A, Kohandel M, Hill R, Sivaloganathan S. Tumour control probability in cancer stem cells hypothesis. PLoS One 2014; 9:e96093. [PMID: 24811314 PMCID: PMC4014481 DOI: 10.1371/journal.pone.0096093] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2013] [Accepted: 04/02/2014] [Indexed: 12/02/2022] Open
Abstract
The tumour control probability (TCP) is a formalism derived to compare various treatment regimens of radiation therapy, defined as the probability that given a prescribed dose of radiation, a tumour has been eradicated or controlled. In the traditional view of cancer, all cells share the ability to divide without limit and thus have the potential to generate a malignant tumour. However, an emerging notion is that only a sub-population of cells, the so-called cancer stem cells (CSCs), are responsible for the initiation and maintenance of the tumour. A key implication of the CSC hypothesis is that these cells must be eradicated to achieve cures, thus we define TCPS as the probability of eradicating CSCs for a given dose of radiation. A cell surface protein expression profile, such as CD44high/CD24low for breast cancer or CD133 for glioma, is often used as a biomarker to monitor CSCs enrichment. However, it is increasingly recognized that not all cells bearing this expression profile are necessarily CSCs, and in particular early generations of progenitor cells may share the same phenotype. Thus, due to the lack of a perfect biomarker for CSCs, we also define a novel measurable TCPCD+, that is the probability of eliminating or controlling biomarker positive cells. Based on these definitions, we use stochastic methods and numerical simulations parameterized for the case of gliomas, to compare the theoretical TCPS and the measurable TCPCD+. We also use the measurable TCP to compare the effect of various radiation protocols.
Collapse
Affiliation(s)
- Andrew Dhawan
- Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario, Canada
- School of Medicine, Queen's University, Kingston, Ontario, Canada
| | - Mohammad Kohandel
- Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario, Canada
- Center for Mathematical Medicine, Fields Institute for Research in Mathematical Sciences, Toronto, Ontario, Canada
- * E-mail:
| | - Richard Hill
- Department of Medical Biophysics, Princess Margaret Hospital, Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada
| | - Sivabal Sivaloganathan
- Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario, Canada
- Center for Mathematical Medicine, Fields Institute for Research in Mathematical Sciences, Toronto, Ontario, Canada
| |
Collapse
|
20
|
dos Santos RV, da Silva LM. The noise and the KISS in the cancer stem cells niche. J Theor Biol 2013; 335:79-87. [DOI: 10.1016/j.jtbi.2013.06.025] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2012] [Revised: 05/08/2013] [Accepted: 06/21/2013] [Indexed: 01/04/2023]
|
21
|
dos Santos RV, da Silva LM. A possible explanation for the variable frequencies of cancer stem cells in tumors. PLoS One 2013; 8:e69131. [PMID: 23950884 PMCID: PMC3737222 DOI: 10.1371/journal.pone.0069131] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2013] [Accepted: 06/04/2013] [Indexed: 12/21/2022] Open
Abstract
A controversy surrounds the frequency of cancer stem cells (CSCs) in solid tumors. Initial studies indicated that these cells had a frequency ranging from 0.0001 to 0.1% of the total cells. Recent studies have shown that this does not always seem to be the case. Some of these studies have indicated a frequency of [Formula: see text]. In this paper we propose a stochastic model that is able to capture this potential variability in the frequency of CSCs among the various type of tumors. Considerations regarding the heterogeneity of the tumor cells and its consequences are included. Possible effects on conventional treatments in clinical practice are also described. The model results suggest that traditional attempts to combat cancer cells with rapid cycling can be very stimulating for the cancer stem cell populations.
Collapse
Affiliation(s)
- Renato Vieira dos Santos
- Departamento de Física, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brasil
| | - Linaena Méricy da Silva
- Laboratório de Patologia Comparada, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brasil
| |
Collapse
|
22
|
Turner C, Kohandel M. Quantitative approaches to cancer stem cells and epithelial-mesenchymal transition. Semin Cancer Biol 2012; 22:374-8. [PMID: 22609094 DOI: 10.1016/j.semcancer.2012.04.005] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2012] [Accepted: 04/16/2012] [Indexed: 01/01/2023]
Abstract
The last decade has witnessed significant advances in the application of mathematical and computational models to biological systems, especially to cancer biology. Here, we present stochastic and deterministic models describing tumour growth based on the cancer stem cell hypothesis, and discuss the application of these models to the epithelial-mesenchymal transition. In particular, we discuss how such quantitative approaches can be used to validate different possible scenarios that can lead to an increase in stem cell activity following induction of epithelial-mesenchymal transition, observed in recent experimental studies on human breast cancer and related cell lines. The utility of comparing mammosphere data to computational mammosphere simulations in elucidating the growth characteristics of mammary (cancer) stem cells is discussed as well.
Collapse
Affiliation(s)
- C Turner
- Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada
| | | |
Collapse
|
23
|
Molina-Peña R, Álvarez MM. A simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growth. PLoS One 2012; 7:e26233. [PMID: 22363395 PMCID: PMC3281810 DOI: 10.1371/journal.pone.0026233] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2011] [Accepted: 09/22/2011] [Indexed: 01/06/2023] Open
Abstract
Background The Cancer Stem Cell (CSC) hypothesis has gained credibility within the cancer research community. According to this hypothesis, a small subpopulation of cells within cancerous tissues exhibits stem-cell-like characteristics and is responsible for the maintenance and proliferation of cancer. Methodologies/Principal Findings We present a simple compartmental pseudo-chemical mathematical model for tumor growth, based on the CSC hypothesis, and derived using a “chemical reaction” approach. We defined three cell subpopulations: CSCs, transit progenitor cells, and differentiated cells. Each event related to cell division, differentiation, or death is then modeled as a chemical reaction. The resulting set of ordinary differential equations was numerically integrated to describe the time evolution of each cell subpopulation and the overall tumor growth. The parameter space was explored to identify combinations of parameter values that produce biologically feasible and consistent scenarios. Conclusions/Significance Certain kinetic relationships apparently must be satisfied to sustain solid tumor growth and to maintain an approximate constant fraction of CSCs in the tumor lower than 0.01 (as experimentally observed): (a) the rate of symmetrical and asymmetrical CSC renewal must be in the same order of magnitude; (b) the intrinsic rate of renewal and differentiation of progenitor cells must be half an order of magnitude higher than the corresponding intrinsic rates for cancer stem cells; (c) the rates of apoptosis of the CSC, transit amplifying progenitor (P) cells, and terminally differentiated (D) cells must be progressively higher by approximately one order of magnitude. Simulation results were consistent with reports that have suggested that encouraging CSC differentiation could be an effective therapeutic strategy for fighting cancer in addition to selective killing or inhibition of symmetric division of CSCs.
Collapse
Affiliation(s)
- Rodolfo Molina-Peña
- Centro de Biotecnología-FEMSA, Tecnológico de Monterrey at Monterrey, Monterrey, Nuevo León, México
| | - Mario Moisés Álvarez
- Centro de Biotecnología-FEMSA, Tecnológico de Monterrey at Monterrey, Monterrey, Nuevo León, México
- * E-mail:
| |
Collapse
|
24
|
The therapeutic implications of plasticity of the cancer stem cell phenotype. PLoS One 2010; 5:e14366. [PMID: 21179426 PMCID: PMC3003707 DOI: 10.1371/journal.pone.0014366] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2010] [Accepted: 11/24/2010] [Indexed: 02/07/2023] Open
Abstract
The cancer stem cell hypothesis suggests that tumors contain a small population of cancer cells that have the ability to undergo symmetric self-renewing cell division. In tumors that follow this model, cancer stem cells produce various kinds of specified precursors that divide a limited number of times before terminally differentiating or undergoing apoptosis. As cells within the tumor mature, they become progressively more restricted in the cell types to which they can give rise. However, in some tumor types, the presence of certain extra- or intracellular signals can induce committed cancer progenitors to revert to a multipotential cancer stem cell state. In this paper, we design a novel mathematical model to investigate the dynamics of tumor progression in such situations, and study the implications of a reversible cancer stem cell phenotype for therapeutic interventions. We find that higher levels of dedifferentiation substantially reduce the effectiveness of therapy directed at cancer stem cells by leading to higher rates of resistance. We conclude that plasticity of the cancer stem cell phenotype is an important determinant of the prognosis of tumors. This model represents the first mathematical investigation of this tumor trait and contributes to a quantitative understanding of cancer.
Collapse
|